20 Live Notices for عوامل الوكلاء المثبطة للمناعة
Showing 1 to 20
Supplies Of Medicinal Products For Drug Programs And Various Drugs
28 Nov 2024
30 Dec 2024Supply Of Medicines With Registration No. 7300011490
Supply of RAVULIZUMAB 300MG/3ML INJ
Supply of BUPROPION 150 MG XL [ WELLBUTRIN XL ]&USTEKINUMAB 130 MG INJECTION&HEPATITIS B VACCINE 20 MICROGRAM/ML&CITANEST WITH OCTAPRESSIN CARTRIDGES&LAMOTRIGINE-1A PHARMA 50 MG TABLET&EPHEDRINE HYDROCHLORIDE INJ 30 MG&BELATACEPT 250MG INJECTION
Purchase And Successive Delivery Of Medicinal Products For Drug And Chemotherapy Programs
Supplies Of Medicinal Products For Drug Programs And Various Drugs
Purchase And Successive Delivery Of Medicinal Products For Drug And Chemotherapy Programs
Lp Containing Golimumab 2024
Medicinal Preparations Containing Golimumab Ii.
Lp Containing Ustekinumab 2024
Lp Containing Arsenic Oxide 2024
Supply Of Medicinal Products And Medical Devices.
Supplies Of Medicines – Medicinal Substance Etanercept – Atc L04Ab01
Medicinal Products Containing Cladribine And Baricitinib
The Medicine Ravulizumab
Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For Drugs With The Active Ingredient Abatacept (Atc Code: L04Aa24).
Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For Drugs With The Active Ingredient Certolizumab Pegol (Atc Code: L04Ab05).
Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For Drugs With The Active Ingredient Tocilizumab (Atc Code: L04Ac07).
Conclusion Of A Non-Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products With The Active Ingredient Fingolimod (Atc Code: L04Aa27).
Conclusion Of A Non-Exclusive Discount Agreement In Accordance With § 130A Paragraph 8 Sgb V For Drugs With The Active Ingredient Infliximab (Atc Code: L04Ab02).
Tenders by Country